Barbier, François
Dupuis, Claire
Buetti, Niccolò
Schwebel, Carole
Azoulay, Élie
Argaud, Laurent
Cohen, Yves
Hong Tuan Ha, Vivien
Gainnier, Marc
Siami, Shidasp
Forel, Jean-Marie
Adrie, Christophe
de Montmollin, Étienne
Reignier, Jean
Ruckly, Stéphane
Zahar, Jean-Ralph
Timsit, Jean-François
,
Article History
Received: 27 September 2023
Accepted: 29 December 2023
First Online: 3 January 2024
Declarations
:
: The OutcomeRéa database protocol was submitted to the Institutional Review Board of the Clermont-Ferrand University Hospital (Clermont-Ferrand, France) who waived the need for informed consent (IRB No. 5891).
: Not applicable.
: F. B. declares having received lecture and consulting fees from MSD, lecture fees for BioMérieux and conference invitation from Pfizer, not related to the submitted work. J.-F. T. declares having received consulting fees from Gilead, MSD, Pfizer, BioMérieux and Roche diagnostic, and lecture fees from MSD, Pfizer, Shionogi, BioMérieux, Qiagen, Mundipharma and Gilead, not related to the submitted work. J.-R. Z. declares having received consulting fees and conference invitation from MSD, consulting fees, lecture fees and conference invitations from Pfizer, lecture Fees from Advanz-Pharma and Shionogui, and conference invitations from Biomérieux and Gilead, not related to the submitted work. E. A. is Associate Editor of <i>Critical Care</i>. Other authors declare having no potential conflict of interest related to the submitted work.